Sanofi gets CDCSO panel okay to study Antiasthmatic drug Dupilumab Dr. Divya Colin9 March 2022 6:58 PM ISTNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
GSK, Sanofi to seek regulatory authorization for COVID vaccine MD Bureau24 Feb 2022 11:00 AM ISTParis: Sanofi and GSK have announced that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory...
Setback: Sanofi to halt Dupixent Phase 3 trial MD Bureau21 Feb 2022 4:50 PM ISTParis: Sanofi has recently announced that the Phase 3 trial (CUPID STUDY B) evaluating Dupixent (dupilumab) in patients with chronic spontaneous...
Sanofi Dupixent under USFDA priority review for kids with atopic dermatitis Ruchika Sharma11 Feb 2022 12:23 PM ISTParis: Sanofi has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the supplemental Biologics...
Sanofi Enjaymo gets USFDA okay for cold agglutinin disease Ruchika Sharma8 Feb 2022 11:43 AM ISTThe US list price, or wholesale acquisition cost, of Enjaymo is $1,800 per vial.
Sanofi unveils new corporate brand, logo Ruchika Sharma5 Feb 2022 2:27 PM ISTParis: Sanofi has unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December...
Novo Nordisk rejects US report on aggressive insulin price hikes Ruchika Sharma3 Feb 2022 1:10 PM ISTThe report contained graphs showing how Novo has raised the price on its rapid-acting insulin Novolog by 628 percent since 2001 by hiking the price 28...
Sanofi, Regeneron get CHMP recommendation for Dupixent approval to treat severe asthma with type 2 inflammation in kids Ruchika Sharma1 Feb 2022 10:00 AM ISTParis: Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the European Medicines Agency's Committee for Medicinal Products for Human...
Ex-Sanofi MD Rajaram Narayanan appointed as SeQuent Scientific MD, CEO Ruchika Sharma18 Jan 2022 12:34 PM ISTMumbai: SeQuent Scientific Limited has recently announced that its Board of Directors has appointed Rajaram Narayanan as Managing Director and Chief...
Sanofi India Managing Director Rajaram Narayanan resigns Ruchika Sharma14 Jan 2022 12:11 PM ISTMumbai: Sanofi India Limited has announced that its Board of Directors have accepted the resignation of its Managing Director, Rajaram Narayanan,...
Lilly Partners with Canadian Pharma Company for therapies for multiple neurologic conditions Medical Dialogues Bureau9 Jan 2022 1:45 PM ISTNDIANAPOLIS - Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research and collaboration agreement with Entos Pharmaceuticals in Canada....
Sanofi partners with AI firm Exscientia to develop up to 15 new drugs Medical Dialogues Bureau8 Jan 2022 3:00 PM ISTNew Delhi: French drugmaker Sanofi SA (SASY.PA) will partner with British AI firm Exscientia Plc (EXAI.O) to develop up to 15 drug candidates across...
